Page last updated: 2024-08-24

carbenoxolone sodium and mrs 2211

carbenoxolone sodium has been researched along with mrs 2211 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alberti, GS; Alvarez, CL; Davio, C; de Tezanos Pinto, F; Espelt, MV; Incicco, J; Leal Denis, MF; Schwarzbaum, PJ	1

Other Studies

1 other study(ies) available for carbenoxolone sodium and mrs 2211

Article	Year
On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells. American journal of physiology. Cell physiology, 2013, May-15, Volume: 304, Issue:10 Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Azo Compounds; Brefeldin A; Carbenoxolone; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Size; Exocytosis; Humans; Hypotonic Solutions; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Protein Synthesis Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2	2013

Article

Year

On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells.

American journal of physiology. Cell physiology, 2013, May-15, Volume: 304, Issue:10

Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Azo Compounds; Brefeldin A; Carbenoxolone; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Size; Exocytosis; Humans; Hypotonic Solutions; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Protein Synthesis Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2

2013